Transcatheter Aortic Valve Replacement Market Global Industry Scenario, Size, Share, Trends, Analysis and Forecast, 2019 - 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Transcatheter Aortic Valve Replacement (TAVR) Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Blood Stream Infe

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Complicated Urinary Tract Infection (cUTI)

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Clostridium difficile infections (CDI)

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Complicated Intra-Abdominal Infections (cIAI)

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Acute Bacterial Skin & Skin Structure Infections (ABSSSI)

4.6.1   Current Trend and Analysis

4.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.7  Community-Acquired Bacterial Pneumonia (CABP)

4.7.1   Current Trend and Analysis

4.7.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.7.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.8  Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)

4.8.1   Current Trend and Analysis

4.8.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.8.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Transcatheter Aortic Valve Replacement (TAVR) Market: by Pathogen: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Pseudomonas aeruginosa (Carbapenem-Resistant)

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Staphylococcus Aureus (Methicillin-Resistant)

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Acinetobacter baumannii (Carbapenem-Resistant and ESBL-producing)

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  E. coli/K. pneumoniae (Carbapenem-Resistant)

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Enterococcus faecium (Vancomycin-Resistant)

5.6.1   Current Trend and Analysis

5.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.7  Haemophilus Influenzae (Ampicillin-Resistant)

5.7.1   Current Trend and Analysis

5.7.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.7.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.8  Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)

5.8.1   Current Trend and Analysis

5.8.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.8.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Transcatheter Aortic Valve Replacement (TAVR) Market by Drug Class: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.2  Lipoglycopeptides

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Lipoglycopeptides

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Cephalosporins

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.5  Tetracyclines

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.6  Combination therapies

6.6.1   Current Trend and Analysis

6.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Transcatheter Aortic Valve Replacement (TAVR) Market by Geography: Market Size and Forecast, 2019 - 2028

7.1  Overview

7.1.1   Global Transcatheter Aortic Valve Replacement(TAVR) Market Year-on-Year Growth, by region 2016 – 2024 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Disease

7.2.3.3        By Pathogen

7.2.3.4        By Drug Type

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Disease

7.2.4.3        By Pathogen

7.2.4.4        By Drug Type

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Disease

7.2.5.3        By Pathogen

7.2.5.4        By Drug Type

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Disease

7.3.3.3        By Pathogen

7.3.3.4        By Drug Type

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Disease

7.3.4.3        By Pathogen

7.3.4.4        By Drug Type

7.3.5   France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Disease

7.3.5.3        By Pathogen

7.3.5.4        By Drug Type

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Disease

7.3.6.3        By Pathogen

7.3.6.4        By Drug Type

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Disease

7.3.7.3        By Pathogen

7.3.7.4        By Drug Type

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Disease

7.3.8.3        By Pathogen

7.3.8.4        By Drug Type

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Disease

7.4.3.3        By Pathogen

7.4.3.4        By Drug Type

7.4.4   India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Disease

7.4.4.3        By Pathogen

7.4.4.4        By Drug Type

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Disease

7.4.5.3        By Pathogen

7.4.5.4        By Drug Type

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Disease

7.4.6.3        By Pathogen

7.4.6.4        By Drug Type

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Disease

7.5.3.3        By Pathogen

7.5.3.4        By Drug Type

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Disease

7.5.4.3        By Pathogen

7.5.4.4        By Drug Type

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Disease

7.5.5.3        By Pathogen

7.5.5.4        By Drug Type

Chapter 8        Company Profiles

8.1  Allergan

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Pfizer

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Johnson & Johnson

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Merck

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  GlaxoSmithKline

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Novartis

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Sanofi

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Melinta Therapeutics

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4Back to top